Article thumbnail

Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in non-viral and adenoviral vectors for gene delivery to nasopharyngeal carcinoma

By Jim Moselhy, Swapna Sarkar, Maria C Chia, Joseph D Mocanu, Nicolas Taulier, Fei-Fei Liu and Xiao Yu Wu

Abstract

Copolymers of 2-dimethyl(aminoethyl) methacrylate (PDMAEM) with N-isopropylacrylamide (NIPAM) were evaluated for their potential to enhance transgene expression of plasmid DNA (pDNA) and gene delivery by adenovirus vectors. The polymers of varying compositions and molecular weights (MW) were synthesized by free-radical polymerization. Polyelectrolyte complexes (PECs) were prepared with different charge (N:P) ratios of PNIPAM/ DMAEM to pDNA. Polymer-modified viral vectors based on non-replicating adenovirus serotype 5 (Ad5), (ΔE1/oriP/luc) or (ΔE1/CMV/luc) transcriptor/promoter/reporter were constructed by electrostatically coupling PNIPAM/DMAEM (Type I) or PECs (oriP/luc, 6.6 kb) (Type II) to the viral capsid. The N:P value at complete condensation was lower for PECs with higher DMAEM content and MW. pDNA binding was enhanced by high MW PNIPAM/DMAEM. Circular dichroism spectroscopy revealed changes to the secondary structure of pDNA and adenovirus capsid proteins in the presence of PNIPAM/DMAEM. The toxicity of PNIPAM/DMAEM to CNE-1 nasopharyngeal cancer (NPC) cells diminished with decreasing DMAEM content and increasing MW. The transfection efficiency of C666-1 NPC cells by PECs increased with DMAEM content and MW. The transduction efficiency of CNE-1 NPC cells by Type I Ad5 vectors improved with DMAEM content, but was independent of MW. The transduction efficiency of Type II Ad5 in C666-1 cells approximated the sum of expression levels of the PECs and Ad5 vectors individually. PDMAEM and PNIPAM/DMAEM demonstrate both transfection and transduction enhancement activity of modified vectors in nasopharyngeal cancer cells in culture

Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2676666
Provided by: PubMed Central

Suggested articles

Citations

  1. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
  2. (2001). Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
  3. (2004). Adenoviral vectors for gene transfer and therapy.
  4. (1998). Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro.
  5. (1996). Adenovirus targeted to heparan-containing receptors increases its gene delivery effi ciency to multiple cell types.
  6. (2005). Advanced targeting strategies for murine retroviral and adeno-associated viral vectors. Adv Biochem Eng Biotechnol,
  7. (1996). Affi nity liposomes in vivo: factors infl uencing target accumulation.
  8. (2003). ATRP synthesis of amphiphilic random, gradient, and block copolymers of 2-(dimethylamino)ethyl methacrylate and n-butyl methacrylate in aqueous media.
  9. (2000). Blood clearance rates of adenovirus type 5 in mice.
  10. (2001). Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther,
  11. (1997). Complexes of adenovirus with polycationic polymers and cationic lipids increase the effi ciency of gene transfer in vitro and in vivo.
  12. (2000). Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents.
  13. (2001). Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy.
  14. (1997). Delivery of bacterial artifi cial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier.
  15. (1985). Determination of MarkHouwink Equation Constant for dimethyl(aminoethyl)methacrylate in different solvents.
  16. (1999). Effi cient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum Gene Ther,
  17. (2006). Effi cient infection of tumor endothelial cells by a capsid-modifi ed adenovirus.
  18. (2005). Evaluation of polyethylene glycol modifi cation of fi rst-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
  19. (2005). Fluorescence dynamics of DNA condensed by the molecular crowding agent poly(ethylene glycol).
  20. (2000). Gene expression control by temperature with thermo-responsive polymeric gene carriers.
  21. (2005). Genetic targeting strategies for adenovirus.
  22. (2000). In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells.
  23. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.
  24. (2000). Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex.
  25. (1999). Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems.
  26. (1999). Modifi cation of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
  27. (2000). Molecular weight characterization of poly(N-isopropylacrylamide) prepared by living free-radical polymerization.
  28. (2002). Moselhy et al Liu FF.
  29. (1994). Multiple adenovirus serotypes use alpha v integrins for infection.
  30. (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
  31. (2000). Non-viral gene delivery for p53.
  32. (2005). PEG shielded polymeric double-layered micelles for gene delivery.
  33. (2004). PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction effi ciency and antibody evasion ability.
  34. (1999). PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.
  35. (2002). PEGylation of E1-deleted adenovirus vectors allows signifi cant gene expression on readministration to liver. Hum Gene Ther,
  36. (1995). Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum Gene Ther,
  37. (1992). Poly(N-isopropylacrylamide): experiment, theory and application. Prog Polym Sci,
  38. (1997). Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery.
  39. (2004). Polyion complex micelles of pDNA with acetal-poly(ethylene glycol)-poly(2-(dimethylamino)ethyl methacrylate) block copolymer as the gene carrier system: physicochemical properties of micelles relevant to gene transfection effi cacy.
  40. (2002). Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection effi ciency.
  41. (1998). Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther,
  42. (2005). Recent advances in non-viral gene delivery.
  43. (1998). Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
  44. (2006). Safi -nya CR.
  45. (1968). Solution properties of poly(N-isopropylacrylamide),
  46. (2001). Stealth” adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for signifi cant gene expression upon readministration in the lung.
  47. (2001). Sterically stabilized polyplex: ligand-mediated activity.
  48. (1997). Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modifi ed adenoviral vectors.
  49. (1995). Synthesis and characterization of thermo- and chemomechanically responsive Poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels.
  50. (1998). Targeted adenoviral vectors for cancer gene therapy. Adv Exp Med Biol,
  51. (2000). Targeting adenovirus.
  52. (2004). Temperature-responsive polymeric carriers incorporating hydrophobic monomers for effective transfection in small doses.
  53. (1968). The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12.
  54. (2004). Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro.
  55. (2005). Thermoresponsive polymers as gene delivery vectors: cell viability, DNA transport and transfection studies.
  56. (1999). Thermosensitive polymers as carriers for DNA delivery.
  57. (2006). Transductional targeting of adenovirus vectors for gene therapy.
  58. (2000). Transfection effi ciency increases by incorporating hydrophobic monomer units into polymeric gene carriers.
  59. (1973). Transformation of rat cells by DNA of human adenovirus 5.
  60. (2002). Tumor-targeted gene therapy for nasopharyngeal carcinoma.
  61. (2006). Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.